Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Rating of “Hold” from Brokerages
02:44am, Sunday, 01'st Feb 2026
Shares of CRISPR Therapeutics AG (NASDAQ: CRSP - Get Free Report) have been given an average rating of "Hold" by the twenty-two research firms that are currently covering the firm, MarketBeat.com repo
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
07:47am, Friday, 30'th Jan 2026
Ark Invest bought shares of Joby Aviation, Kodiak AI, and CRISPR on Thursday. Joby surrendered more in market cap on Thursday than the $1.2 billion dilution investors feared with its stock and convert
Cathie Wood Doubles Down on Joby Aviation After Stock Crashes 17%
07:06am, Friday, 30'th Jan 2026
Cathie Wood's ARK Invest made fresh portfolio adjustments on Thursday, adding to select holdings that recently came under pressure while cutting exposure to sto
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch
12:28pm, Thursday, 29'th Jan 2026
CRISPR Therapeutics is targeting multiple difficult-to-treat diseases with several candidates. The company's shares could soar if it delivers consistent clinical and regulatory progress.
Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops
04:33am, Tuesday, 27'th Jan 2026
Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, amid insider sales, slow revenue growth, and weak adoption of its core pro
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
06:50pm, Monday, 26'th Jan 2026
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.65, marking a -1.57% move from the previous day.
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:11am, Monday, 26'th Jan 2026
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Samarth Kulkarni Sells 30,000 Shares of CRISPR Therapeutics (NASDAQ:CRSP) Stock
05:22am, Saturday, 24'th Jan 2026
CRISPR Therapeutics AG (NASDAQ: CRSP - Get Free Report) CEO Samarth Kulkarni sold 30,000 shares of the company's stock in a transaction on Tuesday, January 20th. The stock was sold at an average price
CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors
07:00pm, Friday, 23'rd Jan 2026
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $55.52, moving 8.7% from the previous trading session.
Cathie Wood's Ark Invest unveiled its "big ideas" for 2025 in a cryptic list, challenging users to interpret a series of custom images called "ARKmoji" to understand their picks for the year.
Why Tech Fund Manager Cathie Wood Sees a ‘Golden Age’ for US Stocks Ahead
08:00am, Monday, 19'th Jan 2026
ARK Invest CEO Cathie Wood, known for big bets on disruptive technologies, said she see strong gains for U.S. equities in the next few years.
CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Thursday, 15'th Jan 2026
CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21, signifying a -4.71% move from its prior day's close.
Crispr Therapeutics: Patience And Opportunity Through Volatility
11:30am, Wednesday, 14'th Jan 2026
Crispr Therapeutics remains highly volatile, disconnected from near-term fundamentals, yet I see long-term value far above current levels. CRSP's business progress is slow, with pipeline milestones an
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
10:01am, Tuesday, 13'th Jan 2026
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:36pm, Monday, 12'th Jan 2026
CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
